Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD in Europe
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, reposted from EAHAD on LinkedIn:
”Understanding access to diagnostic tools and treatment options for von Willebrand disease across Europe is essential to improving care and identifying unmet needs.
I encourage all healthcare professionals involved in the diagnosis and treatment of VWD across Europe to take a few minutes to participate in this survey and share their experience.
Your input will help provide a clearer picture of current practice and resource availability across different clinical settings.”
Quoting European Association for Haemophilia and Allied Disorders (EAHAD)‘s post:
”The EAHAD von Willebrand Disease (VWD) Working Group has launched a new survey to assess the availability of diagnostic tools and treatment options across European medical centers.
The aim is to better understand current clinical practice, available resources, and real-world access to care across different settings.
We invite healthcare professionals to contribute their experience and insights.
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:23Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants